At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Soothe VRdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Virtual Reality on Pain and Patient Satisfaction in Adults Receiving Genicular Nerve Radiofrequency Ablation
In Brief
A clinical study evaluating Soothe VR for Pain and Patient Satisfaction. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The study team aims to investigate whether implementing virtual reality therapy (VRT) during Genicular nerve radiofrequency ablation (GNRFA) procedure will provide better alleviation of procedural pain and augmented satisfaction for patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Patient Satisfaction
CountriesUnited States
CollaboratorsApplied VR
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartDec 2020
First PostedJul 2022
Primary CompletionSep 2024
Study CompletionDec 2024
TodayJul 2026
First PostedJul 21, 2022
Enrollment StartDec 2, 2020
Primary CompletionSep 6, 2024
Study CompletionDec 14, 2024
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 3.9 years ago
Interventions
Soothe VRdevice
The Soothe VR system is manufactured by Applied VR. It is a HIPAA-compliant platform and has been validated by randomized control trials. It has not yet been reviewed by the FDA.